Skip to content

Study · Not a test of the peptide alone · 2016

2 results

Development of the intein-mediated method for production of recombinant thymosin β4 from the acetylated in vivo fusion protein.

Esipov RS, Makarov DA, Stepanenko VN, Miroshnikov AI

Journal of biotechnology22 Mar 2016Cited by 5 (Europe PMC)

PMID27015974 (opens in a new tab)DOI10.1016/j.jbiotec.2016.02.021 (opens in a new tab)PepBankPUB-27015974
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymosin beta-4 (human).

  1. 01LabNot a test of Thymosin beta-4 (human) aloneOther designOther

    In the engineered expression system, formyl methionine was completely removed from the Tβ4 N-terminus and the Tβ4 precursor was acetylated at the N-terminus.

    In plain wordsIn a lab production system, recombinant Tβ4 was made with the correct acetylated start.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    Not applicableIn vivo N-terminal acetylation of recombinant Tβ4
    Study

    n: not reported in source

    Outcome group
    Synthesis and manufacturing · Pharmacology

    Source sentences

    Summary
    In the process of the post-translational modification in vivo formyl methionine was completely removed from the target peptide N-terminus and followed by the Tβ4 precursor N-terminal acetylation.

    In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin beta-4 (human).

  2. 02LabNot a test of Thymosin beta-4 (human) aloneOther designOther

    The intein-mediated expression system made it possible to extract Tβ4 in only 2 chromatographic runs.

    In plain wordsIn a lab production system, Tβ4 was purified in only 2 chromatography runs.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    Not applicablePurification of recombinant Tβ4 in chromatographic runs
    Study

    n: not reported in source

    Outcome group
    Synthesis and manufacturing · Pharmacology

    Measurements

    chromatographic runs
    2 runs
    Tβ4 extraction

    Source sentences

    Summary
    The use of the intein-mediated expression system made it possible to extract thymosin β4 in only 2 chromatographic runs.

    In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin beta-4 (human).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.